The PSA density was calculated in 98 patients with carcinoma of the pr
ostate by using the weight and/or volume of the radical prostatectomy
specimen. In 22 of 98 patients, PSA serum levels ranged between 4 and
10 ng/ml. Eleven patients showed PSA serum levels below 4 ng/ml and 65
patients above 10 ng/ml. Sixty-one of the 65 patients with PSA serum
levels > 10 ng/ml had PSAD values above 0.15, and we therefore suspect
ed the presence of carcinoma of the prostate according to Benson et al
. Twelve of the 22 patients with PSA serum levels between 4 and 10 ng/
ml had PSAD values below the cut-off value of 0.15. In addition, all 1
1 patients with PSA values < 4 ng/ml showed PSAD values < 0.15, a rang
e that can be regarded as almost harmless according to Benson et al. I
n conclusion, it seems apparent that in patients with PSA serum levels
< 10 ng/ml, no important additional information is obtained from the
PSAD determination. Routine measurement of PSAD for evaluating the ris
k of carcinoma of the prostate in individual cases can therefore not b
e recommended.